健神利水颗粒联合呋塞米治疗脑出血继发性脑水肿的临床研究

Abstract
Figure/Table
References (27)
Related Citation (15)

Download: PDF (594 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Jianshi Lishui Granules combined with Furosemide in the treatment of secondary cerebral edema after cerebral hemorrhage. Methods A total of 100 patients with secondary cerebral edema after cerebral hemorrhage admitted to the First Affiliated Hospital of Guangxi University of Chinese Medicine from April 2017 to April 2020 were selected and they were divided into control group and study group according to random number table method, with 50 cases in each group. The control group was treated with Furosemide, and the study group was treated with Jianshi Lishui Granules on the basis of the control group. Both groups were treated for 14 days. The efficacy, the United States national institutes of health stroke scale (NIHSS) score, hypersensitive C-reactive protein (hs-CRP), S-100β protein, interleukin-1β (IL-1β), hematoma volume, cerebral edema volume, peak systolic blood flow velocity, average blood flow velocity, cerebral blood flow and incidence of adverse reactions were compared between the two groups. Results The clinical total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P ＜ 0.05). After treatment, NIHSS scores in both groups were decreased compared with before treatment, and those in the study group were lower than those in the control group, with statistical significance (all P ＜ 0.05). After treatment, average blood flow velocity, peak systolic blood flow velocity and cerebral blood flow in both groups were increased compared with before treatment, and those in the study group were higher than those in the control group, with statistical significance (all P ＜ 0.05). After treatment, hs-CRP, S-100β protein and IL-1β were decreased in both groups compared with before treatment, and those in the study group were lower than those in the control group, with statistical significance (all P ＜ 0.05). After treatment, hematoma volume and cerebral edema volume in both groups were decreased compared with before treatment, and the those in the study group were smaller than those in the control group, with statistical significance (all P ＜ 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P ＞ 0.05). Conclusion In the treatment of secondary cerebral edema after cerebral hemorrhage, Jianshi Lishui Granules combined with Furosemide can promote the reduction of hematoma volume and cerebral edema volume, improve cerebral blood flow, reduce the inflammatory response and peroxidation damage of brain tissue, and reduce the injury of brain tissue, with definite curative effect.

Key words： Jianshi Lishui Granules Furosemide Secondary cerebral edema after cerebral hemorrhage Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	TAN Lulu1 HUANG Rongsen2 ZHOU Guan2 CHEN Xinghua1 LIU Yonghui1

Cite this article:

TAN Lulu1 HUANG Rongsen2 ZHOU Guan2 CHEN Xinghua1 LIU Yonghui1. Clinical study of Jianshi Lishui Granules combined with Furosemide in the treatment of secondary cerebral edema after cerebral hemorrhage[J]. 中国医药导报, 2021, 18(14): 72-75,80.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I14/72

[1] 艾池波.脑出血继发性水肿及血肿扩大治疗的临床研究进展[J].中西医结合心脑血管病杂志，2020，18（8）：1250-1252.
[2] 王丽琴，安娜，田超，等.活血化瘀法治疗脑出血作用机制实验研究进展[J].中国实验方剂学杂志，2020，26（5）：220-226.
[3] 黄绍精，曲军，陈新.托拉塞米与呋塞米治疗急性脑出血后脑水肿疗效[J].宁夏医科大学学报，2016，38（7）：807-810.
[4] 黄树武.两种脑出血模型的比较及健神利水颗粒对脑出血大鼠神经元凋亡的影响[D].南宁：广西中医药大学，2015.
[5] 张祥建，张丽英.脑血管病的诊治思路与技巧[J].中国全科医学，2004，7（18）：1312-1313.
[6] 王培，李迪，李深.表现为低美国国立卫生研究院卒中量表评分的前循环大血管闭塞的急性缺血性卒中治疗进展[J].中华神经科杂志，2020，53（9）：727-731.
[7] 吴秋月，蒋艳.脑出血患者早期活动的研究进展[J].护士进修杂志，2020，35（19）：1762-1765.
[8] 吴炯星，王德任.脑出血后重启抗凝治疗的研究进展[J].中国卒中杂志，2020，15（1）：45-50.
[9] 杨庆晓，关文明，宋彬，等.急性脑出血患者血清ICAM-1、cFN水平与炎性因子相关性及预后的危险因素分析[J].疑难病杂志，2019，18（6）：549-553，558.
[10] 朱芸，许国春.过度通气与呋塞米持续静滴联合治疗小儿感染性脑水肿[J].中国实用神经疾病杂志，2016，19（20）：123-125.
[11] 许翔.甘油果糖联合呋塞米治疗急性脑出血后脑水肿效果研究[J].实用中西医结合临床，2020，20（3）：51-52.
[12] 谭璐璐，陈兴华.健神利水颗粒联合甘露醇防治脑梗死继发脑疝临床研究[J].河南中医，2016，36（9）：1548-1549.
[13] 刘泰，高玉广，黄树武，等.健神利水颗粒对实验性脑出血大鼠caveolin-1表达的影响[J].时珍国医国药，2015， 26（11）：2625-2627.
[14] 陈炜，黄树武，高玉广，等.健神利水颗粒对脑出血大鼠神经功能损害及神经元细胞凋亡的影响[J].药学研究，2015（9）：497-499，516.
[15] 陈生，陈然，吴章松，等.龙琥醒脑颗粒联合西医治疗对脑出血后脑水肿患者脑脊液IL-1β、S-100蛋白水平的影响[J].新疆医科大学学报，2019，42（9）：1193-1197.
[16] 李震，陈磊，肖明，等.醒脑静注射液在急性脑出血治疗中的临床疗效和安全性[J].世界中医药，2019，14（3）：661-665.
[17] 林存山，杨晓莉，候清，等.高血压脑出血患者外周血NLRP3及IL-1β和IL-18水平与预后的关系[J].西部医学，2020，32（6）：854-858.
[18] 肖小华.清热化瘀汤对急性脑出血患者血清hs-CRP、血浆S100β蛋白和NSE的影响[J].中医药信息，2020， 37（1）：100-104.
[19] 王小言，夏鹰，金虎，等.白虎汤加味联合小牛血清去蛋白对脑出血急性期血清超敏C反应蛋白以及血浆S100β蛋白的影响[J].中华中医药学刊，2020，38（6）：222-225.
[20] 张燕.祛瘀豁痰中药治疗高血压性脑出血疗效及对hs-CRP、NPY、NSE水平的影响[J].现代中西医结合杂志，2018，27（1）：67-70.
[21] 黄艳丽，张海垠.局部亚低温治疗对高血压性脑出血患者血清hs-CRP及Hcy水平的影响研究[J].中国实验诊断学，2020，24（1）：11-14.
[22] 张青萍，黄树武，何青，等.健神利水颗粒方理论探源[J].时珍国医国药，2015，26（1）：172-173.
[23] 孙永康，王新志，杨海燕.王新志教授治疗脑出血与脑梗死用药比较[J].中西医结合心脑血管病杂志，2020， 18（12）：1973-1975.
[24] 张方，李文杰.益气活血利水颗粒对急性脑出血后脑水肿的临床疗效及对MMP-9的影响[J].中国实用神经疾病杂志，2016，19（1）：42-44.
[25] 时高波，白慧.大柴胡汤加桂枝茯苓丸治疗急性脑出血35例[J].河南中医，2018，38（4）：518-520.
[26] 席乐迎，任献青，许爽，等.基于网络药理学的中药作用机制研究进展[J].现代中西医结合杂志，2020，29（29）：3287-3290，3296.
[27] 庞会婷，罗朵生，郭姣.三七化学成分分析及其抗炎机制的网络药理学探讨[J].中草药，2020，51（21）：5538-5547.